![]() |
|
|
Vol. 61, Issue 1, 214-221, January 2002
Molecular Nutrition Unit, Institute of Nutritional Science, Technical University of Munich, Freising-Weihenstephan, Germany (S.T., G.K., H.D.); and the Institute of Biochemistry, Department of Biochemistry/Biotechnology of the Martin-Luther-University Halle-Wittenberg, Halle, Germany (B.H., K.N.)
| |
Abstract |
|---|
|
|
|---|
The peptide transporter PEPT2, expressed in a variety of tissues,
including kidney, lung, and the central nervous system, mediates the
uphill transport of di- and tripeptides, as well as a variety of
peptidomimetic drugs. To identify the essential molecular features of
substrates that determine affinity and transport by PEPT2, we
synthesized a series of amino acid derivatives as well as modified
dipeptides. Kinetic constants for the interaction of test compounds
with PEPT2 were obtained in a competition assay using Pichia
pastoris yeast cells expressing mammalian PEPT2. The
two-electrode voltage-clamp technique in Xenopus laevis
oocytes was used to assess the substrate's electrogenic transport
properties. Whereas
-amino fatty acids showed no affinity for PEPT2,
the introduction of a single carbonyl group into the backbone increased both affinity and transport currents more than 30-fold.
-Amino fatty
acids, at their amino or carboxyl group coupled to an alanine residue,
allowed us to determine the importance of the spatial position of
functional groups within the molecule. Affinity and transport function
declined by elongating the
-amino acid chain when located in the
N-terminal position, whereas the elongation in the carboxyl terminal
with an N-terminal alanine caused less pronounced effects. The results
clearly establish that a free N terminus, a correctly positioned
backbone carbonyl group, and a carboxylic group that is in a suitable
distance from the intramolecular carbonyl function and the amino
terminal head group are the main features for substrate recognition and
transport by PEPT2. This information provides the framework for a
rational design of peptidomimetic drugs for delivery via PEPT2.
| |
Introduction |
|---|
|
|
|---|
The
mammalian H+/peptide transporter PEPT2 is
responsible for the rapid and efficient uptake of a large number of
different di- and tripeptides as well as various peptidomimetics across the plasma membrane of kidney tubular cells, lung epithelia, and mammalian brain cells (Ganapathy et al., 1983
; Daniel et al., 1991
; Liu
et al., 1995
; Boll et al., 1996
; Leibach et al., 1996
). The transporter
acts as a high-affinity/low-capacity system transporting its substrates
in a proton-coupled electrogenic mode (Boll et al., 1996
). The
intestinal peptide transporter PEPT1, belonging to the same family as
PEPT2, mediates the uptake of di- and tripeptides and derivatives into
intestinal epithelial cells in a similar mode. PEPT1 has been studied
extensively with respect to substrate specificity, and findings allowed
the formulation of preliminary predictive models for substrate
recognition (Borner et al., 1998
; Brandsch et al., 1998
, 1999
;
Döring et al., 1998d
; Meredith et al., 1998
). In previous
studies (Döring et al., 1998d
), we showed that PEPT1
transports
-amino fatty acids electrogenically with affinities that
are similar to those of native dipeptides. By using
-amino fatty
acids of increasing chain length, the minimal molecular requirements
for substrate-PEPT1 interactions were defined as free terminal amino
and carboxylic groups separated by at least four methylene groups.
Another study demonstrated that amino acid arylamides are recognized by
PEPT1 as high-affinity substrates (Borner et al., 1998
) and that the
replacement of the native peptide bond by a thioxo-peptide bond is also
well-tolerated by PEPT1 (Brandsch et al., 1998
). These and other data
obtained in different expression systems for PEPT1 of different species
were used for the first modeling approaches to obtain a template for
the interaction within the substrate-binding domain (Bailey et al.,
2000
).
It is well-established that PEPT2 has similar but not identical requirements for substrate recognition and transport. Generally much higher affinities are determined for the majority of PEPT2 substrates. However, systematic studies on the minimal structural features of substrate binding are not yet available for the cloned PEPT2 protein covering a larger set of substrates. Because PEPT2 is expressed in a variety of tissues, including kidney, lung, and the central nervous system, defining its substrate template could also be of importance for a rational design of pharmacologically active compounds for a targeted delivery.
To define the key substrate-recognition criteria, we synthesized a
variety of amino acid arylamides as well as modified dipeptides containing
-amino acids as probes. Using Pichia pastoris
yeast cells expressing PEPT2 (Döring et al., 1998b
), we
first determined the affinity of the test compounds for interaction
with PEPT2 by their ability to compete for the uptake of the
radiolabeled dipeptide D-Phe-Ala. To be able to
differentiate between compounds that only interact with the
substrate-binding site of the transporter and those that are
electrogenically transported via PEPT2, we performed an
electrophysiological analysis of inward currents induced by the
substrates in Xenopus laevis oocytes expressing PEPT2 (Boll
et al., 1996
). Although partially different test compounds were used in
the present study compared with those used to study PEPT1, experiments
were performed under the same experimental conditions as those reported
previously (Döring et al., 1998a
). This format also
permits a comparison of the observed differences between the two
transporters with respect to substrate specificity for binding and transport.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials.
Female X. laevis oocytes were
purchased from Nasco (Fort Atkinson, WI).
Glycyl-L-glutamine (Gly-Gln) was obtained from
Sigma Chemie (Deisenhofen, Germany); D-Phe-Ala
was purchased from Bachem (Heidelberg, Germany). Custom-synthesized
[3H]D-Phe-Ala (specific
radioactivity, 40 Ci/mmol) was obtained from Biotrend (Köln,
Germany), and collagenase A was obtained from Roche Molecular
Biochemicals (Mannheim, Germany). Substrates and precursors were
purchased from Sigma Chemie. All noncommercially available test
compounds were synthesized according to standard procedures (Wunsch,
1974
; Barth et al., 1980
) in peptide chemistry.
P. pastoris Strains and Transport Assays in
Yeast.
Cultures of P. pastoris strains expressing PEPT2
were prepared as described previously (Döring et al.,
1998b
). Cells were centrifuged at 3000g for 10 min
and formed into a pellet, washed twice with 100 mM potassium phosphate
buffer (PPB; pH 6.5), and resuspended to 5 × 107 cells/20 µl of PPB. Uptake measurements
were performed at 22 to 24°C using a rapid-filtration technique on
96-well filter plates (filter material HATF type, 0.45-µM pore
size; Millipore Corporation, Eschborn, Germany). In brief, uptake was
initiated by mixing 20 µl of the cell suspension with 30 µl of PPB
containing 0.05 µCi of
[3H]D-Phe-Ala either with
or without competitors (final concentration, 0.0001-20 mM). After 15 min of incubation, the uptake was terminated by the addition of 200 µl of ice-cold PPB followed by filtration. The filters were washed
four more times with 200 µl of PPB, removed from the plate with a
punch, and transferred into vials. Radioactivity associated with the
filter was measured by liquid-scintillation counting.
X. laevis Oocytes Expressing PEPT2 and
Electrophysiology.
Surgically removed oocytes were separated by
collagenase treatment and handled as described previously (Boll et al.,
1996
). Individual oocytes were injected with 30 nl of RNA solution
containing 30 ng of rabbit PEPT2 cRNA. All electrophysiological
measurements were performed after 3 to 6 days by the incubation of
oocytes in a buffer composed of 88 mM NaCl, 1 mM KCl, 0.82 mM
CaCl2, 0.41 mM MgCl2, 0.33 mM Ca(NO3)2, 2.4 mM
NaHCO3, and 10 mM MES/Tris at pH 6.5 (modified
Barth's solution).
were connected to a TEC-05 amplifier (NPI Electronic, Tamm,
Germany). PEPT2 expressing oocytes were voltage-clamped at
60 mV, and
current-voltage (I-V) relationships were measured using short pulses
(100 ms) separated by 200-ms pauses in the potential range from
160
to +40 mV. I-V measurements were made immediately before and 30 s
after substrate application, when current flow reached steady state.
Currents evoked by PEPT2 at a given membrane potential were calculated
as the difference of the currents measured in the presence and absence
of substrate. Each substrate was tested against the maximal inward
current elicited by 5 mM Gly-Gln, allowing for a comparison of current
recordings that are independent of the level of functional expression
of various oocyte batches. The electrophysiological measurement data are representative of at least two independent experiments and different oocyte batches.
Statistics. All calculations (linear as well as nonlinear regression analyses) were performed using Prism software (GraphPAD, San Diego, CA). At least two independent experiments with three replicates were carried out for each variable. Data are given as mean ± S.E.M.
| |
Results |
|---|
|
|
|---|
The apparent substrate affinity of each of the test compounds was determined by using a competition assay taken from PEPT2 expressing P. pastoris yeast cells. Additionally, substrates were studied for electrogenic transport via PEPT2 by the two-electrode voltage-clamp technique in PEPT2 expressing X. laevis oocytes. This approach, derived from two independent transport assays, allowed us to distinguish between compounds that only interact with the substrate-binding site and those that are also transported across the membrane after binding.
Role of the Carbonyl Group for Substrate Affinity of PEPT2.
As
recently shown (Döring et al., 1998d
),
-amino fatty
acids are transported by the intestinal peptide transporter PEPT1 when
expressed heterologously in yeast cells and oocytes. Electrogenic transport of
-amino fatty acids requires the two head groups (amino
and carboxyl terminals) to be separated by at least four methylene
groups serving as an intramolecular spacer. These compounds, therefore,
clearly defined the minimal molecular requirements for a substrate
interaction with PEPT1. For this reason, we used 5-aminopentanoic acid
(5-APA) as the smallest amino fatty acid recognized and transported by
PEPT1 to determine whether the same minimal substrate requirements
apply to PEPT2 (Table 1). Whereas the
affinity of 5-APA for PEPT1 was 1.14 mM (Döring et al.,
1998c
), which is in the range of native dipeptide substrates of PEPT1, its affinity for PEPT2 was 7.28 ± 1.32 mM (Fig.
1A), which was far below that which is
characteristic for PEPT2 substrates (Amasheh et al., 1997
). Similar
results were obtained for several other
-amino fatty acids (data not
shown). In addition, the very low affinity of 8-aminooctanoic acid for
interaction with PEPT2 has also been demonstrated in LLC-PK1
cells transfected with rat PEPT2 (Terada et al., 2000
). It therefore
can be concluded that
-amino fatty acids are not substrates of
PEPT2. However, when we incorporated a carbonyl group into the backbone
of 5-APA (yielding 5-amino-4-oxopentanoic acid), the affinity increased
more than 30-fold to 0.22 ± 0.01 mM (Fig. 1A, Table 1), which is
comparable with that of normal PEPT2 substrates; electrogenic transport
characteristics typical of PEPT2 were obtained. It is likely that
5-amino-4-oxopentanoic acid can serve as a substrate because it mimics
the dipeptide Gly-Gly, in which the peptide bond is replaced by a
ketomethylene function. On the contrary, the Gly-Gly derivative
N-
-aminoethyl-Gly, with a reduced peptide bond lacking
the carbonyl function but still containing the nitrogen of the Gly-Gly
peptide bond, shows no interaction with PEPT2
(Ki > 10 mM). Thus, it is obvious that indeed the carbonyl group plays the essential role.
|
|
Importance of the Location of the Carbonyl Group within the
Backbone.
Because
-amino fatty acids are very flexible, it is
difficult to obtain information about the spatial location of
functionally important groups within such molecules. To determine the
importance of the molecular distance between the terminal amino
function and the backbone carbonyl group, we used a series of modified dipeptides consisting of an
-amino acid with a different chain length at the N terminus and an alanine residue in the C-terminal position (Table 1). The smallest of these compounds, glycyl-alanine, displayed an affinity of 0.11 ± 0.01 mM, as expected for a
standard dipeptide (Fig. 2A). Lengthening
this molecule by just one methylene group incorporated between the
amino group and the amide bond (
-Ala-Ala) already reduced the
affinity 8-fold to 0.93 ± 0.01 mM (Fig. 2A, Table 1). In parallel
to the decrease in affinity, the substrate-evoked inward currents
decreased to only 50% IGly-Gln (Fig. 2B).
Successive lengthening of the
-amino acid chain by methylene units
resulted in a further dramatic decline in affinity to 5.61 ± 0.22 mM for 4-ABA-Ala and up to 25.1 ± 6.4 mM for 7-aminoheptanoic acid-Ala (Fig. 2A, Table 1). Carbamoyl-
-Ala, a Gly-Gly derivative in
which the amide bond is shifted to the N terminus so that a methylene
unit between the N-terminal amino group and the amide bond is lacking,
showed no interaction with PEPT2. This signifies that a minimal
distance between the carbonyl function and the N-terminal amino group
must be kept to obtain an interaction with the peptide carrier (Fig.
1A, Table 1).
|
Importance and Sterical Localization of the C-Terminal Carboxylic
Group.
To obtain more information on the importance of the
terminal carboxylic group of substrates on the affinity for PEPT2, we synthesized a series of dipeptides with opposite sequences carrying an
N-terminal alanine residue and C-terminal
-amino acids of increasing
chain length (Table 1). In the first substrate of this series,
alanyl-glycine, the distance from the amide bond to the terminal
carboxylic group is prototypical for dipeptides. Consequently,
alanyl-glycine shows a high affinity of 0.07 ± 0.01 mM (Fig.
3A, Table 1) and an expected high
substrate-evoked inward current of 95% IGly-Gln
(Fig. 3B). The elongation of the
-amino acid chain by one methylene
group (Ala-
-Ala) reduced the affinity by approximately 4-fold to
0.39 ± 0.09 mM, and currents
although measured under substrate
saturation of PEPT2
declined to 26% IGly-Gln. Introducing additional -CH2 units (Ala-4-ABA and
Ala-5-APA), however, increased both the affinity and currents to
0.12 ± 0.03 mM and 50% IGly-Gln in the
case of Ala-4-ABA and 0.06 ± 0.02 mM and 91% IGly-Gln in the case of Ala-5-APA, respectively
(Fig. 3, A and B; Table 1). The introduction of additional methylene
groups (Ala-6-aminohexanoic acid) again resulted in a 6-fold decline in
affinity (0.76 ± 0.07 mM) and lower substrate-evoked inward currents (Fig. 3, A and B; Table 1).
|
-amino acid, our considerably
flexible test compounds may more or less adopt a conformation in which
the terminal COO
group is accommodated in a
proper orientation with the required distance between the amide bond
and the binding site for the C-terminal carboxyl group, as in native
di- and tripeptides.
However, it remains to be answered whether a C-terminal carboxylic
function is required at all for substrate recognition. Recent findings
demonstrated that amino acid arylamides completely lacking a terminal
carboxylic group serve as substrates for PEPT1 (Borner et al., 1998
|
|
group of Ala-4-aminobenzoic acid
was moved from the para- to the meta- position,
substrate affinity increased almost 50-fold to 0.056 ± 0.003 mM
and transport currents yielded 54% of IGly-Gln,
which are characteristics similar to that of native di- or tripeptides
(Fig. 5). Ala-3-aminobenzoic acid can, by
its structure, be considered a perfect tripeptide mimetic with the same
affinity constant and transport rate as trialanine
(Ki = 0.23 ± 0.06 mM, 76%
IGly-Gln; data not shown). When the carboxylic group attached to the phenyl ring was moved to the ortho-
position, the affinity increased only 5-fold compared with
alanine-4-aminobenzoic acid, but even at saturating substrate
concentrations, no transport currents were recorded.
|
| |
Discussion |
|---|
|
|
|---|
Defining the minimal structural features in substrates for binding
and transport by PEPT2 is important for understanding the protein
structure and for the development of peptidomimetic drugs or prodrugs
that can use PEPT2 for uptake into cells expressing this carrier
protein. In contrast to PEPT1, PEPT2 failed to transport
-amino
fatty acids such as 5-APA. However, the introduction of a carbonyl
group into the backbone of 5-APA to obtain 5-amino-4-oxopentanoic acid
yielded a substrate with normal affinity and electrogenic transport
properties. This establishes that this carbonyl function plays an
essential role in substrate recognition by PEPT2. The data obtained for
-amino acyl-alanine dipeptides demonstrate the specific requirements
of PEPT2 with respect to the optimal positioning of the free amino
function relative to the backbone carbonyl group. Although it has
already been known that a free terminal amino group is important for
high-affinity renal peptide transport (Daniel et al., 1992
), we
demonstrate here that the terminal nitrogen atom and the identified
essential backbone carbonyl group should be separated by the distance
of one or at most two methylene groups from each other to enable
high-affinity interaction and transport of a substrate. The marked
reduction of affinity by shifting the amino group from
to
position has recently also been observed in the case of rat PEPT2
(Terada et al., 2000
).
By applying the alanyl-
-amino acid dipeptides, we also obtained
detailed information on the importance of the positioning of the
terminal carboxylic group for interaction with PEPT2. Although partly
similar in chain length, the tested compounds are more flexible in
conformation than tri- or tetrapeptides. Tripeptides, as well as
dipeptides, are transported by PEPT2 (Boll et al., 1996
; Döring
et al., 1997
). It is obvious that for high-affinity and electrogenic
transport, a second peptide bond is not required, and even in the case
of substances that, formally seen, exceed the chain length of a
tripeptide, good binding and transport properties can be observed.
More striking is the finding that Ala-anilides carrying different substituents show a wide range of affinities and quite different transport characteristics. Analysis of the importance of the various para-substituents attached to the phenyl ring showed that higher F values corresponding to the Swain-Lupton constants correlated with lower Ki values and increased affinity for binding to PEPT2, suggesting that the electronic density at the aromatic ring system is differently affected by the inductive and mesomeric properties of the para-substituents; this translates into quite large differences in affinities of the Ala-anilides. The varying electronic densities may affect binding to PEPT2, either by a direct interaction of the ring system with amino acid residues within the substrate-binding pocket of the protein or by a transmission of the electrogenic effects along the phenyl ring system onto the adjacent essential carbonyl function, altering its relative charge for interaction with the transporter.
The finding that Ala-4-nitroanilide displays a high-affinity
interaction with PEPT2 but is itself not transported into the cells is
surprising because data obtained with Caco-2 cells and X. laevis oocytes expressing the intestinal peptide transporter isoform PEPT1 demonstrated that Ala-4-nitroanilide is transported electrogenically (Borner et al., 1998
). This establishes that despite
the similarities in substrate recognition by PEPT1 and PEPT2, there are
major differences regarding the ability to transport this class of
compounds electrogenically.
Taken together, our results suggest that for the transport of the
Ala-anilide derivatives, the para-substituent needs to be rather small and uncharged, whereas a negatively charged group in this
fixed position at the rigid phenyl ring prevents any interaction with
the substrate-binding pocket. Because the COO
group could electrostatically interact with amino acid side chains of
the transporter protein at this position, we may have identified a
critical functional protein domain in PEPT2 that accommodates only
structures that allow hydrophobic interactions.
However, we also show here that substrates with identical N-terminal
structures (alanine) but with terminal carboxylic groups attached to
-amino acids of different chain length cannot only bind with high
affinity; they are transported, too. The major difference between these
compounds and the Ala-4-aminobenzoic acid is, of course, the alkyl
spacer of the
-amino acids, which possesses conformational
flexibility allowing the COO
group to be
accommodated in a proper orientation within the substrate-binding domain. In the more rigid alanine-4-aminobenzoic acid, the
COO
group is sterically fixed and therefore
probably prevents substrate binding within an obviously narrowly
defined domain of the binding pocket. To target this domain in view of
its specific requirements, we synthesized two additional
alanine-aminobenzoic acid derivatives with the carboxylic acid
substituent now provided in either ortho- or
meta- position of the phenyl ring and determined the
affinities and transport currents. The observed dramatic alterations in
substrate affinity just by changing the spatial position of the
COO
substituent at the phenyl ring clearly
identifies a very important region within the substrate-binding pocket
of PEPT2 that can discriminate those substrates from being bound or
not. Even more important is the observation that only the
meta-substituted form allows electrogenic transport. This
seems best explained by the fact that only in this structure, the
COO
group is located in a similar sterical
position and distance to the essential N-terminal nitrogen and the
required backbone carbonyl function, as in the terminal
COO
group in native tripeptides (Fig. 5A). We
also observed that blocking the COO
group in
the meta- position by esterification (Ala-3-aminobenzoic acid methyl ester) retains the compound's high affinity for PEPT2 but
prevents its electrogenic transport (Ki = 0.19 ± 0.06 mM, 5% IGly-Gln; data not
shown). This further emphasizes the importance of the nature and
sterical position of the substrate's COO
group
for binding and transport.
Translocation by PEPT2 of substrates that carry a terminal carboxylic
group in addition to a free amino terminus and the backbone carbonyl
group is only possible if the COO
group comes
into a narrowly defined spatial position within the protein-binding
pocket, regardless of the overall affinity of the substrate. This is an
important finding because these compounds now can be used in
combination with single-site mutants of PEPT2 to identify the
critical
most likely positively charged
amino acid residue in the
substrate-binding region of PEPT2 that obviously controls the
conformational change in the protein necessary for substrate proton translocation.
In summary, we show that there are major differences between PEPT2 and
the intestinal isoform PEPT1, not only with respect to substrate
affinity, but more importantly in view of the requirements for
electrogenic transport. By rational design of novel amino acid anilides
and modified dipeptides consisting of an N- or C-terminal
-amino
acid and an
-amino acid in the opposite position, the minimal
structural and chemical requirements for substrate recognition and
transport by PEPT2 have been defined in terms of the essential backbone
length, important functional groups, and their relative spatial
location within the substrate-binding domain of PEPT2.
| |
Footnotes |
|---|
Received May 29, 2001; Accepted October 9, 2001
This work was supported by Deutsche Forschungsgemeinschaft grant Da 190/6-1, by Land Sachsen-Anhalt grant 2880A/0028G, and by the Fonds der Chemischen Industrie.
Prof. Dr. Hannelore Daniel, Institute of Nutritional Sciences, Technical University of Munich, Hochfeldweg 2, D-85350 Freising-Weihenstephan, Germany. E-mail: daniel{at}wzw.tum
| |
Abbreviations |
|---|
Gly-Gln, glycyl-L-glutamine; PPB, potassium phosphate buffer; MES, 2-(N-morpholino)ethanesulfonic acid; 4-ABA, 4-aminobutanoic acid; 5-APA, 5-aminopentanoic acid; Ala, alanine; D-Phe-Ala, D-phenylalanyl-L-alanine; I, current; I-V, current-voltage; IGly-Gln, current elicited by glycyl-L-glutamine.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. Weitz, D. Harder, F. Casagrande, D. Fotiadis, P. Obrdlik, B. Kelety, and H. Daniel Functional and Structural Characterization of a Prokaryotic Peptide Transporter with Features Similar to Mammalian PEPT1 J. Biol. Chem., February 2, 2007; 282(5): 2832 - 2839. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Meyer, S. Eskandari, S. Grallath, and D. Rentsch AtGAT1, a High Affinity Transporter for {gamma}-Aminobutyric Acid in Arabidopsis thaliana J. Biol. Chem., March 17, 2006; 281(11): 7197 - 7204. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shen, R. F. Keep, Y. Hu, and D. E. Smith PEPT2 (Slc15a2)-Mediated Unidirectional Transport of Cefadroxil from Cerebrospinal Fluid into Choroid Plexus J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1101 - 1108. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Foltz, A. Meyer, S. Theis, H.-U. Demuth, and H. Daniel A Rapid in Vitro Screening for Delivery of Peptide-Derived Peptidase Inhibitors as Potential Drug Candidates via Epithelial Peptide Transporters J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 695 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Groneberg, A. Fischer, K. F. Chung, and H. Daniel Molecular Mechanisms of Pulmonary Peptidomimetic Drug and Peptide Transport Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 251 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kottra, A. Stamfort, and H. Daniel PEPT1 as a Paradigm for Membrane Carriers That Mediate Electrogenic Bidirectional Transport of Anionic, Cationic, and Neutral Substrates J. Biol. Chem., August 30, 2002; 277(36): 32683 - 32691. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||